Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

Author： Schwartz Sherwyn   Etropolski Mila   Shapiro Douglas Y.   Okamoto Akiko   Lange Robert   Haeussler Juergen   Rauschkolb Christine  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.1, 2011-01, pp. : 151-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo‐controlled trial

By  

JOURNAL OF DIABETES, Vol. 10, Iss. 3, 2018-03 ,pp. : 256-265

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy

By Freeman Roy   Raskin Philip   Hewitt David J.   Vorsanger Gary J.   Jordan Donna M.   Xiang Jim   Rosenthal Norman R.    

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-01 ,pp. : 147-161

Informa Healthcare

Access to resources Recommend Favorite

Tolvaptan in hospitalized cancer patients with hyponatremia: A double‐blind, randomized, placebo‐controlled clinical trial on efficacy and safety

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 744-751

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of high‐dose pravastatin in hypercholesterolemic patients with well‐compensated chronic liver disease: Results of a prospective, randomized, double‐blind, placebo‐controlled, multicenter trial

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1453-1463

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 11, 2015-11 ,pp. : 1056-1064

John Wiley & Sons Inc

Access to resources Recommend Favorite